News Fine pharma for price gouging, says Clinton Hillary Clinton wants to fine companies for gouging prices of generics.
News Clinton attacks Mylan over drug pricing Presidential hopeful criticises "outrageous" EpiPen price increase.
News German pricing changes to hit blockbuster revenues But pharma will be able to negotiate confidential prices.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
